Submissions from 2017
Fetal Outcomes After Diabetic Ketoacidosis During Pregnancy, Fritha J R Morrison, Maryam Movassaghian, Ellen W. Seely, Ashley Curran, Maria Shubina, Emma Morton-Eggleston, Chloe A. Zera, Jeffrey L. Ecker, Florence M. Brown, and Alexander Turchin
Submissions from 2016
Practical combination therapy based on pathophysiology of type 2 diabetes, Philip A. Levin
Measurements of CD34+/CD45-dim Stem Cells Predict Healing of Diabetic Neuropathic Wounds, Stephen R. Thom, Michelle Hampton, Michael A. Troiano, Ziad Mirza, D Scot Malay, Steven Shannon, Nathan B. Jennato, Cornelius M. Donohue, Ole Hoffstad, Diana Woltereck, Ming Yang, Kevin Yu, Veena M. Bhopale, Svitlana Kovtun, and David J. Margolis
Submissions from 2015
Health Outcomes Associated with Initiation of Basal Insulin After 1, 2, or ≥ 3 Oral Antidiabetes Drug(s) Among Managed Care Patients with Type 2 Diabetes, Philip A. Levin, Steve Zhou, Jasvinder Gill, and Wenhui Wei